MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014; Nature Portfolio; Volume: 515; Issue: 7528 Linguagem: Inglês
10.1038/nature13904
ISSN1476-4687
AutoresThomas Powles, Joseph P. Eder, Gregg Fine, Fadi S. Braiteh, Yohann Loriot, Cristina Cruz, Joaquim Bellmunt, Howard A. Burris, Daniel P. Petrylak, Siew-leng Melinda Teng, Xiaodong Shen, Zachary Boyd, Priti S. Hegde, Daniel S. Chen, Nicholas J. Vogelzang,
Tópico(s)Immunotherapy and Immune Responses
Referência(s)